Case of metastatic uveal melanoma in which an antitumor effect appeared after ipilimumab discontinuation due to autoimmune hypophysitis

J Dermatol. 2017 Nov;44(11):1325-1326. doi: 10.1111/1346-8138.13692. Epub 2016 Nov 18.

Authors

Takehiro Ohnuma¹, Takamitsu Matsuzawa¹, Manao Kinoshita¹, Shinya Sano¹, Tatsuyoshi Kawamura¹, Shinji Shimada¹, Takashi Inozume¹

Affiliation

¹ Department of Dermatology, University of Yamanashi, Chuo, Japan.

PMID: 27864834
DOI: 10.1111/1346-8138.13692

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Immunological / therapeutic use*
Autoimmune Hypophysitis / chemically induced*
Female
Humans
Ipilimumab / therapeutic use*
Melanoma / diagnostic imaging
Melanoma / drug therapy*
Melanoma / pathology
Melanoma / secondary
Middle Aged
Nivolumab / therapeutic use*
Treatment Failure
Uveal Melanoma
Uveal Neoplasms / pathology

Substances

Antineoplastic Agents, Immunological
Ipilimumab
Nivolumab